Healthcare & Biotech
Alixia
Targeting the Tumor Ecosystem to address cancer drug resistance.
Our compounds disrupt the metabolic and inflammatory triggers in both cancer and quasi-cancerous cells in the tumor microenvironment. By impacting multiple cell types, we are enabling effective, lasting cancer treatments.
- Therapeutics
- Biotech
- Drug discovery
- Website
- alixia.com
- Headquarters
- San Francisco, CA, USA
- Team size
- 2-10 people
- Founded
- 2022
- Demo
- 45 min demo
Similar companies
Eris BiotechOur drugs engage the immune system to fight tumors
Origami Therapeutics, Inc.Oral drugs to halt neurodegeneration
Yemaachi BiotechnologyDiversifying precision cancer diagnostics and treatments
Entelexo BiotherapeuticsCreating a New Class of Drugs to Address Incurable Autoimmune Diseases
Equator TherapeuticsWe are developing a drug to burn calories and increase metabolism…
Velorum TherapeuticsBreakthrough medicines unlocking the biology of heme
Sensible BiotechnologiesUnlocking the next generation of mRNA medicines
Serinus BiosciencesCombinations therapy by rational design